# India Neurology Devices Market > India Neurology Devices Market Research Report: Size, Share, Trend Analysis By Product Type (neurostimulation, interventional neurology, CSF management, neurosurgery devices) and By End-user (hospitals & clinics, specialty center) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.82% - **2024:** $ 941.28 Million - **2025:** $ 1,014.89 Million - **2035:** $ 2,155 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott (US), NeuroPace (US), Natus Medical (US), Stryker (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) **Report ID:** MRFR/MED/50067-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-neurology-devices-market-51825 --- ## Market Summary ## **India Neurology Devices Market Overview** As per MRFR analysis, the India Neurology Devices Market Size was estimated at 0.73 (USD Billion) in 2023.The India Neurology Devices Market is expected to grow from 1.2(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The India Neurology Devices Market CAGR (growth rate) is expected to be around 10.221% during the forecast period (2025 - 2035). **Key India Neurology Devices Market Trends Highlighted** The rising incidence of neurological conditions, improvements in medical technology, and rising healthcare costs are driving a number of significant developments in the Indian neurology devices market. The need for cutting-edge neurology devices is being driven in large part by the increase in disorders including stroke, epilepsy, and neurodegenerative conditions like Parkinson's and Alzheimer's. Government health reports state that the significant burden of these illnesses is driving both the public and commercial sectors to invest in the development of cutting-edge diagnostic and therapeutic tools, which has increased the use of neurostimulation devices and minimally invasive procedures. Opportunities in this market should also be investigated, such as the continuous development of India's healthcare system, especially in rural regions, which gives producers of neurology devices access to a larger patient base. It is also significant that telemedicine and digital health solutions are becoming more popular since they allow for remote monitoring and consultation, which eventually improves patient care for neurological disorders. India's focus on increasing domestic manufacturing through programs like "Make in India" further promotes regional neurological device production, which can increase patient accessibility and affordability. Increased cooperation between manufacturers and tech companies has resulted in the creation of smart devices that integrate data analytics and artificial intelligence, according to recent trends in the India neurology devices market. These developments increase treatment results in addition to increasing diagnostic precision. Additionally, the Indian population's growing awareness of neurological health encourages patients to advocate for improved treatment alternatives, which advances the industry. All things considered, the changing environment bodes well for the Indian neurology devices market, with a number of factors influencing its course of expansion. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Neurology Devices Market Drivers** **Increasing Prevalence of Neurological Disorders** India is witnessing a notable rise in the incidence of neurological disorders, significantly driving the India Neurology Devices Market. Reports indicate that around 6 to 7 million people suffer from epilepsy in India, resulting in an increased demand for devices such as neurostimulators and diagnostic equipment. Moreover, according to the Indian Council of Medical Research, there has been a 10% annual increase in reported cases of neurological conditions over the past five years. With the population of over 1.4 billion, as recorded in the 2021 Census of India, and a growing elderly demographic, the pressure on healthcare systems to address these conditions is intensifying. Leading companies like GE Healthcare and Siemens Healthineers are ramping up their R&D efforts to develop innovative neurology devices, providing crucial support to the healthcare sector and shaping the evolution of the India Neurology Devices Market. **Advancements in Technology and Innovation** Technological advancements play a vital role in bolstering the India Neurology Devices Market. Innovations such as minimally invasive surgical techniques are gaining traction, improving outcome rates for patients with neurological disorders. A study by the Department of Health Research in India highlighted that there has been a 25% increase in the adoption of image-guided neurosurgery in the last three years. Additionally, companies like Medtronic and Johnson & Johnson are continuously investing in Research and Development to enhance neurostimulation devices, which are critical in treating conditions like Parkinson's disease. The influx of startups focused on neurology innovations is also contributing to a dynamic market environment, leading to further growth in the India Neurology Devices Market. **Government Initiatives and Support** The Indian government has implemented various initiatives aimed at improving healthcare infrastructure, significantly influencing the growth of the India Neurology Devices Market. The National Health Mission and Ayushman Bharat schemes are designed to increase access to healthcare services, emphasizing neurological care. According to the Ministry of Health and Family Welfare, the government has allocated over 370 billion INR for health initiatives in the recent budget, facilitating improvements in hospital facilities and availability of medical devices. Additionally, collaborations between government bodies and private organizations are fostering a supportive ecosystem for the development of advanced neurology devices, providing a significant boost to the India Neurology Devices Market. **India Neurology Devices Market Segment Insights** **Neurology Devices Market Product Type Insights** The India Neurology Devices Market is experiencing a significant evolution, driven by advancements in technology and an increasing prevalence of neurological disorders. Within the Product Type segment, the market comprises various crucial areas, including neurostimulation, interventional neurology, cerebrospinal fluid (CSF) management, and neurosurgery devices. Neurostimulation has emerged as a dominant force, addressing conditions such as epilepsy and chronic pain, and offers improved patient outcomes with less invasive approaches. The interventional neurology segment is also critical, facilitating procedures like thrombectomy and stent placement, which are essential in treating stroke patients. CSF management devices play a vital role in addressing conditions like hydrocephalus, ensuring the proper flow and drainage of cerebrospinal fluid which is crucial for brain health. Lastly, the neurosurgery devices segment encompasses a range of surgical tools and implantable devices providing advanced solutions for complex surgical interventions. The considerable investments in Research and Development (R&D) by both public and private sectors in India further underpin the growth of the India Neurology Devices Market, fostering innovative solutions tailored to the unique needs of the Indian population. Additionally, increasing healthcare expenditure and government initiatives aimed at enhancing healthcare infrastructure are contributing to the strong demand within this segment. The rising awareness of neurological conditions among the population, coupled with educational campaigns on early diagnosis and treatment, is also propelling market growth. Overall, the Product Type segment reflects a detailed landscape of opportunities driven by technological advancements, regulatory support, and an ever-evolving understanding of neurological health challenges in India. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Neurology Devices Market****End-use****r Insights** The End-user segment of the India Neurology Devices Market plays a critical role in the overall growth of the industry. Hospitals and clinics are essential as they provide primary healthcare services and advanced neurological treatments. The increasing incidence of neurological disorders in India has heightened the demand for effective diagnostic and therapeutic equipment, making hospitals a vital segment in the market. Meanwhile, specialty centers focus on specialized neurological care, including surgeries and rehabilitation, thus driving technological advancements and innovation in devices. These centers cater to complex cases and offer tailored treatments, which are becoming increasingly significant in a country where patients seek faster and more efficient healthcare solutions. The growing elderly population in India, coupled with rising awareness about neurological conditions, supports further growth and development in these facilities. Additionally, advancements in technology and increased healthcare spending contribute to the strengthening of these segments, ensuring that they remain pivotal in the evolving landscape of the India Neurology Devices Market. As they adapt to new treatments and technologies, both hospitals and specialty centers are pivotal in shaping the future of neurological care in India, effectively addressing a wide range of health issues and enhancing patient outcomes. **India Neurology Devices Market Key Players and Competitive Insights** The India Neurology Devices Market is characterized by a dynamic competitive landscape driven by technological advancements and increasing investments in healthcare. As the healthcare infrastructure in India continues to evolve, the demand for innovative neurology devices is rising, propelled by factors such as an increase in neurological disorders, heightened awareness about mental health, and the government’s focus on improving healthcare services. Various companies are competing to capture market share by introducing advanced products and improving existing offerings, thus fostering an environment of innovation and competition. Additionally, collaborations, partnerships, and strategic alliances play a crucial role in determining the competitive dynamics as companies seek to enhance their market presence through various channels. ZymeQuest has established itself as a notable player within the India Neurology Devices Market, primarily due to its specialized focus on developing innovative medical devices designed to address neurological conditions. The company leverages cutting-edge technology and a strong R&D base, allowing it to launch products that cater specifically to the needs of neurological patients in India. ZymeQuest's strengths lie in its ability to respond quickly to market demands and regulatory changes, alongside its commitment to quality and efficacy. By fostering strategic collaborations and maintaining a robust supply chain, ZymeQuest has effectively positioned itself to capitalize on the growing demand for neurology devices, gaining a competitive edge in the Indian market. Abbott Laboratories is a well-established player in the India Neurology Devices Market, known for its comprehensive portfolio of products that target various neurological conditions. Key offerings include advanced neurostimulation devices, imaging technologies, and diagnostic tools tailored for the Indian healthcare landscape. Abbott Laboratories benefits from a strong brand reputation and extensive distribution network, enabling it to effectively reach healthcare professionals and institutions across the country. The company's ability to innovate and adapt its product offerings in response to local needs is a significant strength, contributing to its solid market presence. Over the years, Abbott Laboratories has executed strategic mergers and acquisitions aimed at enhancing its technological capabilities and expanding its service offerings. This proactive approach ensures that it remains competitive in a rapidly evolving market, aligning with the growing demands of neurological healthcare in India. **Key Companies in the India Neurology Devices Market Include:** - ZymeQuest - Abbott Laboratories - Johnson & Johnson - Stimwave - B. Braun - LivaNova - NICO Corporation - NeuroPace - Boston Scientific - Stryker - Medtronic - ElectroCore - Cerenovus - Haemonetics - Medytox **India Neurology Devices****Market****Developments** The India Neurology Devices Market has seen significant developments recently, with major players such as Abbott Laboratories, Johnson and Johnson, and Medtronic actively expanding their product lines and enhancing their market presence. In July 2023, it was reported that Medtronic had announced a new range of implantable devices aimed at treating various neurological disorders in India, reflecting the growing demand for advanced healthcare solutions. Similarly, Boston Scientific and Stryker have been investing in Research and Development to innovate product offerings tailored to Indian patients. Furthermore, recent mergers and acquisitions continue to shape the market landscape. In August 2023, it was announced that ZymeQuest acquired a division of LivaNova focused on trauma and neurologic products, strengthening ZymeQuest's portfolio in India. Recent growth has also been noted, with the market valuation for neurology devices experiencing a steady increase, attributed to the rising incidence of neurological disorders in the country. The last couple of years have witnessed an upward trajectory in the market as more companies establish local manufacturing units, thus enhancing accessibility and affordability of neurology devices for the Indian population. **India Neurology Devices Market Segmentation Insights** **Neurology Devices Market Product Type Outlook** - neurostimulation - interventional neurology - CSF management - neurosurgery devices **Neurology Devices Market End-user Outlook** - hospitals & clinics - specialty center ## Market Drivers ### Investment in Healthcare Infrastructure Investment in healthcare infrastructure in India is significantly impacting the neurology devices market. The government has been actively enhancing healthcare facilities, particularly in rural areas, to ensure better access to medical services. Initiatives such as the National Health Mission aim to strengthen healthcare delivery systems, which includes the procurement of advanced medical devices. In 2025, the Indian healthcare sector is projected to reach a market size of $372 billion, with a substantial portion allocated to neurology devices. This investment is likely to facilitate the adoption of cutting-edge technologies, including MRI machines and EEG devices, which are essential for diagnosing and treating neurological conditions. As healthcare infrastructure improves, the availability and accessibility of neurology devices are expected to increase, thereby driving market growth and enhancing patient care. ### Rising Incidence of Neurological Disorders The increasing prevalence of neurological disorders in India is a primary driver for the neurology devices market. Conditions such as epilepsy, Alzheimer's disease, and Parkinson's disease are becoming more common, affecting millions of individuals. According to recent estimates, approximately 6.5 million people in India suffer from dementia, with a significant portion being undiagnosed. This rising incidence necessitates advanced diagnostic and therapeutic devices, thereby propelling market growth. The demand for innovative solutions, including neurostimulation devices and imaging technologies, is likely to surge as healthcare providers seek to improve patient outcomes. Furthermore, the aging population in India, which is projected to reach 300 million by 2050, is expected to exacerbate the situation, leading to a greater need for effective neurology devices. Thus, the growing burden of neurological disorders is a crucial factor influencing the neurology devices market in India. ### Increased Focus on Research and Development Increased focus on research and development (R&D) in the field of neurology is a vital driver for the neurology devices market in India. Both public and private sectors are investing heavily in R&D to develop innovative solutions for neurological disorders. Government initiatives, such as the Biotechnology Industry Research Assistance Council, are providing funding and support for research projects aimed at advancing neurology devices. In 2025, the R&D expenditure in the healthcare sector is projected to reach $10 billion, with a significant portion directed towards neurology. This emphasis on innovation is likely to lead to the introduction of novel devices, including advanced neuroimaging systems and therapeutic devices. As research progresses, it is expected that new technologies will emerge, further propelling the growth of the neurology devices market and improving treatment options for patients. ### Technological Innovations in Device Development Technological innovations are transforming the neurology devices market in India. The advent of artificial intelligence (AI) and machine learning is enabling the development of sophisticated diagnostic tools and treatment devices. For instance, AI-driven imaging technologies are enhancing the accuracy of diagnoses, while wearable devices are providing real-time monitoring of neurological conditions. The market for wearable neurology devices is anticipated to grow at a CAGR of 15% over the next five years, reflecting the increasing demand for remote patient monitoring solutions. Additionally, advancements in neurostimulation techniques are leading to more effective treatments for chronic pain and movement disorders. These innovations not only improve patient outcomes but also attract investment from both public and private sectors, further stimulating the neurology devices market. As technology continues to evolve, it is likely to play a pivotal role in shaping the future of neurology devices in India. ### Growing Demand for Minimally Invasive Procedures The growing preference for minimally invasive procedures is significantly influencing the neurology devices market in India. Patients and healthcare providers are increasingly opting for techniques that reduce recovery time and minimize surgical risks. This trend is evident in the rising use of endovascular procedures for treating conditions such as aneurysms and arteriovenous malformations. The market for minimally invasive neurology devices is projected to expand as more hospitals adopt these techniques. In 2025, the market for neurovascular devices alone is expected to reach $1.2 billion, driven by the demand for safer and more effective treatment options. Furthermore, advancements in device design and technology are making these procedures more accessible, thereby enhancing patient satisfaction and outcomes. Consequently, the shift towards minimally invasive approaches is a key driver of growth in the neurology devices market. ## Future Outlook The [Neurology Devices Market](https://www.marketresearchfuture.com/reports/neurology-devices-market-9768) in India is projected to grow at a 7.82% CAGR from 2025 to 2035, driven by technological advancements, increasing neurological disorders, and rising healthcare expenditure. **New opportunities:** - Development of portable EEG monitoring devices for home use. - Expansion of telemedicine platforms for remote neurological consultations. - Investment in AI-driven diagnostic tools for early detection of neurological conditions. By 2035, the neurology devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Neurostimulation (Largest) vs. Interventional Neurology (Fastest-Growing) The India neurology devices market exhibits a diverse distribution of segment values, with neurostimulation leading as the largest segment. This segment captures a significant portion of the market share, driven by its wide range of applications in patient treatment and management. Interventional neurology, while slightly smaller in share, is rapidly gaining traction due to advancements in minimally invasive techniques and technology, appealing to both healthcare providers and patients alike. Growth trends in this market are largely influenced by the increasing prevalence of neurological disorders and the growing demand for effective therapeutic options. The rise of innovative technologies in neurostimulation enhances patient outcomes and contributes to its dominance. Meanwhile, interventional neurology is set to experience an accelerated growth rate, fueled by the surge in neurovascular treatments and the emphasis on patient-centric care, solidifying its position as a vital and fast-evolving segment. Neurostimulation (Dominant) vs. CSF Management (Emerging) Neurostimulation devices are recognized for their pivotal role in managing chronic pain, epilepsy, and movement disorders, making them the dominant force in the India neurology devices market. This segment is characterized by a broad range of products, including deep brain stimulators and spinal cord stimulators, which see widespread adoption in clinical settings. On the other hand, cerebrospinal fluid (CSF) management devices, though emerging, showcase significant potential for growth. These devices, focused on treating conditions like hydrocephalus, are gaining popularity due to their essential role in improving patient quality of life and advancing from traditional methods to new, innovative solutions. ### By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing) In the India neurology devices market, Hospitals & Clinics dominate the End User segment, accounting for a significant portion of the overall market share. Their expansive infrastructure and essential services make them the preferred choice for neurological treatments, enabling them to cater to a larger patient base. In comparison, Specialty Centers, while smaller in market share, are rapidly gaining traction due to their focused expertise in specific neurological conditions. This shift reflects a growing inclination towards specialized care among patients. Growth trends in the End User segment show a remarkable increase in demand for both Hospitals & Clinics and Specialty Centers. Key drivers include the rising prevalence of neurological disorders, advancements in neurology devices, and the growing emphasis on specialized treatment options. The adaptability of Specialty Centers to incorporate innovative technologies and personalized treatment plans positions them well for future growth, attracting more patients seeking targeted care and improved outcomes. Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging) Hospitals & Clinics in the India neurology devices market stand out as the dominant segment, characterized by their comprehensive service offerings and wide reach. They provide a range of neurological treatments, supported by advanced diagnostic and therapeutic devices. This extensive capability ensures they remain the first point of contact for patients with neurological issues. On the other hand, Specialty Centers are emerging rapidly, focusing on specific disorders such as epilepsy, Parkinson's disease, and multiple sclerosis. Their specialized approach allows for tailored treatments, resulting in high patient satisfaction and better management of complex conditions. As patient awareness increases, the appeal of these centers is growing, positioning them as a vital component of the neurology healthcare ecosystem. ## Competitive Benchmarking The neurology devices market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing healthcare demands. Key players such as Medtronic (US), Boston Scientific (US), and Abbott (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Medtronic (US) emphasizes its commitment to developing cutting-edge neuromodulation therapies, while Boston Scientific (US) is actively expanding its product portfolio through acquisitions and collaborations. Abbott (US) is leveraging its strong research capabilities to introduce novel diagnostic and therapeutic solutions, thereby shaping a competitive environment that prioritizes innovation and patient-centric approaches. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for share. However, the collective influence of major companies is significant, as they drive technological advancements and set industry standards. This competitive structure fosters an environment where innovation is paramount, compelling companies to continuously enhance their offerings to maintain relevance. In October 2025, Medtronic (US) announced the launch of a new line of advanced neurostimulation devices aimed at treating chronic pain. This strategic move is likely to strengthen its position in the market by addressing unmet medical needs and expanding its customer base. The introduction of these devices not only showcases Medtronic's commitment to innovation but also reflects a broader trend towards [personalized medicine](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937)in neurology. In September 2025, Boston Scientific (US) completed the acquisition of a promising neurotechnology startup, which specializes in minimally invasive procedures for neurological disorders. This acquisition is expected to enhance Boston Scientific's capabilities in the neurology devices sector, allowing it to offer more comprehensive solutions. The integration of advanced technologies from the startup could potentially lead to improved patient outcomes and increased market competitiveness. In August 2025, Abbott (US) launched a new digital platform designed to streamline the management of neurological conditions. This platform integrates artificial intelligence to provide real-time data analytics, enabling healthcare providers to make informed decisions. Abbott's focus on digital transformation aligns with current trends in the healthcare sector, where data-driven solutions are becoming increasingly vital for effective patient management. As of November 2025, the competitive trends in the neurology devices market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among companies are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident. Moving forward, competitive differentiation will likely hinge on the ability to innovate and adapt to evolving market demands, positioning companies to thrive in an increasingly complex environment. ## Recent News & Developments The India Neurology Devices Market has seen significant developments recently, with major players such as Abbott Laboratories, Johnson and Johnson, and Medtronic actively expanding their product lines and enhancing their market presence. In July 2023, it was reported that Medtronic had announced a new range of implantable devices aimed at treating various neurological disorders in India, reflecting the growing demand for advanced healthcare solutions. Similarly, Boston Scientific and Stryker have been investing in Research and Development to innovate product offerings tailored to Indian patients. Furthermore, recent mergers and acquisitions continue to shape the market landscape. In August 2023, it was announced that ZymeQuest acquired a division of LivaNova focused on trauma and neurologic products, strengthening ZymeQuest's portfolio in India. Recent growth has also been noted, with the market valuation for neurology devices experiencing a steady increase, attributed to the rising incidence of neurological disorders in the country. The last couple of years have witnessed an upward trajectory in the market as more companies establish local manufacturing units, thus enhancing accessibility and affordability of neurology devices for the Indian population. ## Report Scope | MARKET SIZE 2024 | 941.28(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1014.89(USD Million) | | MARKET SIZE 2035 | 2155.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.82% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott (US), NeuroPace (US), Natus Medical (US), Stryker (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) | | Segments Covered | Product, End User | | Key Market Opportunities | Advancements in neurostimulation technologies present growth opportunities in the neurology devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the neurology devices market, enhancing patient care and treatment options. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India neurology devices market?** A: The market valuation was $941.28 Million in 2024. **Q: What is the projected market size for the India neurology devices market by 2035?** A: The projected valuation for 2035 is $2155.0 Million. **Q: What is the expected CAGR for the India neurology devices market during 2025 - 2035?** A: The expected CAGR during this period is 7.82%. **Q: Which companies are the key players in the India neurology devices market?** A: Key players include Medtronic, Boston Scientific, Abbott, NeuroPace, Natus Medical, Stryker, LivaNova, ElectroCore, and Cerenovus. **Q: What are the main product segments in the India neurology devices market?** A: Main segments include Neurostimulation, Interventional Neurology, CSF Management, and Neurosurgery Devices. **Q: What was the market size for Neurostimulation in 2024?** A: The market size for Neurostimulation was $188.25 Million in 2024. **Q: What is the projected market size for Interventional Neurology by 2035?** A: The projected market size for Interventional Neurology is $640.0 Million by 2035. **Q: How much did the CSF Management segment generate in 2024?** A: The CSF Management segment generated $188.25 Million in 2024. **Q: What is the expected market size for hospitals and clinics in the neurology devices market by 2035?** A: The expected market size for hospitals and clinics is $1400.0 Million by 2035. **Q: What was the market size for specialty centers in 2024?** A: The market size for specialty centers was $341.28 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-neurology-devices-market-51825*